0000950170-24-068811.txt : 20240604 0000950170-24-068811.hdr.sgml : 20240604 20240604170016 ACCESSION NUMBER: 0000950170-24-068811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240601 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calhoun Philip Gregory CENTRAL INDEX KEY: 0001836702 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39280 FILM NUMBER: 241019136 MAIL ADDRESS: STREET 1: 2100 WHITES BRIDGE ROAD CITY: COLQUITT STATE: GA ZIP: 39837 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Danimer Scientific, Inc. CENTRAL INDEX KEY: 0001779020 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 841924518 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 INDUSTRIAL BOULEVARD CITY: BAINBRIDGE STATE: GA ZIP: 39817 BUSINESS PHONE: 229-243-7075 MAIL ADDRESS: STREET 1: 140 INDUSTRIAL BOULEVARD CITY: BAINBRIDGE STATE: GA ZIP: 39817 FORMER COMPANY: FORMER CONFORMED NAME: Danimer Scientific, Inc DATE OF NAME CHANGE: 20201229 FORMER COMPANY: FORMER CONFORMED NAME: Live Oak Acquisition Corp DATE OF NAME CHANGE: 20200106 FORMER COMPANY: FORMER CONFORMED NAME: Foxhound Merger Partners, Inc. DATE OF NAME CHANGE: 20190605 4 1 ownership.xml 4 X0508 4 2024-06-01 0001779020 Danimer Scientific, Inc. DNMR 0001836702 Calhoun Philip Gregory C/O DANIMER SCIENTIFIC INC. 140 INDUSTRIAL BOULEVARD BAINBRIDGE GA 39817 true false false false false Class A Common Stock 2024-06-01 4 M false 16611 0.00 A 277551 D Class A Common Stock 3457004 I Greg Calhoun DGT Family Trusts GST Exempt Class A Common Stock 67351 I Greg Calhoun DGT Family Trusts GST Non-Exempt Restricted Stock Units 2024-06-01 4 M false 16611 0.00 D Common Stock 16611 0 D These shares are owned by the Greg Calhoun DGT Family Trusts u/t/a dated September 22, 2020 GST Exempt Trust. The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. These shares are owned by the Greg Calhoun DGT Family Trusts u/t/a dated September 22, 2020 Non-GST Exempt Trust. Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock. Comprised of an award of restricted stock units (RSU) granted as director compensation under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") with each RSU representing the right to receive one share of Danimer Scientific Class A Common Stock. All of these RSU's will vest and become non-forfeitable on June 1, 2024 subject to recipient's continued service as a director of the Company. /s/ Stephen A. Martin, attorney-in-fact 2024-06-04 EX-24.1 2 dnmr-ex24_1.htm EX-24.1 EX-24.1

 

 

 

 

 

 

LIMITED POWER OF ATTORNEY FOR

SECTION 16 REPORTING AND FORM 144 NOTICE OBLIGATIONS

Know all by these presents, that the undersigned's hereby makes, constitutes and appoints Stephen A. Martin, Spencer E. Walker, Michael S. Nancarrow, and Blake R. Chamblee as the undersigned's true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:

(1)
prepare, execute, acknowledge, deliver and file (i) Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Danimer Scientific, Inc., a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act") and (ii) any Notice of Proposed Sale of Securities on Form 144 (and any amendments thereto) in accordance with Rule 144 under the Securities Act of 1933, as amended (the "Securities Act");
(2)
seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and
(3)
perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

(1)
this Limited Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information;
(2)
any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;
(3)
neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act or the Securities Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and
(4)
this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act, or under the Securities Act, including without limitation the compliance with Rule 144 under the Securities Act.

The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be don

 

in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holding of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to such attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 2nd day of June, 2023.

 

/s/ Philip Gregory Calhoun

Signature

 

Philip Gregory Calhoun

Print Name